Clinical outcomes of surgical resection vs yttrium 90 radioembolization (Y90) in hepatocellular carcinoma (HCC) patients with macrovascular invasion (MVI)

被引：0

作者：

Zou, Zhaozhen ^{[1
]}

Goh, Brian ^{[2
]}

Cheow, Peng Chung ^{[2
]}

Chung, Alexander ^{[2
]}

Ooi, London Lucien ^{[2
]}

Ng, David Chee Eng ^{[3
]}

Lo, Richard Hoau Gong ^{[4
]}

Kumar, Karaddi Venkatanarasimha Nanda ^{[4
]}

Gogna, Apoorva ^{[4
]}

Too, Chow Wei ^{[4
]}

Irani, Farah ^{[4
]}

Yan, Sean Xuexian

Loke, Kelvin Siu Hoong ^{[3
]}

Thang, Sue Ping ^{[3
]}

Tong, Aaron Kian Ti ^{[3
]}

Huang, Hian Liang ^{[3
]}

Chen, Kaina ^{[5
]}

Moe, Fiona Ni Ni ^{[6
]}

Ng, Weng Yan ^{[6
]}

Chua, Siou Sze ^{[6
]}

Goh, Jade Shu Qi ^{[6
]}

Chow, Pierce ^{[1
,2
]}

机构：

[1] Duke NUS Med Sch, Singapore, Singapore

[2] Singapore Gen Hosp, Dept Hepatopancreatobiliary & Transplantat Surg, Singapore, Singapore

[3] Singapore Gen Hosp, Dept Nucl Med & Mol Imaging, Singapore, Singapore

[4] Singapore Gen Hosp, Dept Vasc & Intervent Radiol, Singapore, Singapore

[5] Singapore Gen Hosp, Dept Gastroenterol, Singapore, Singapore

[6] Natl Canc Ctr Singapore, Singapore, Singapore

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-142

引用

页码：S591 / S592

页数：2

共 50 条

[21] SBRT vs. Y90 HCC Treatment Outcomes and Costs
deBettencourt, Mark F.
Liu, Yirong
Cotler, Scott J.
Molvar, Chris A.
Abdelrahman, Tamer
Thomas, Tarita O.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (03): : 99 - 104
[22] Efficacy and Predictors of Survival Using Yttrium 90 (y90) Therasphere Treatment for Hepatocellular Carcinoma
Sheikh, Maheen
Gerkin, Richard
Seetharam, Anil B.
Wood, David
GASTROENTEROLOGY, 2015, 148 (04) : S1028 - S1028
[23] Is Y90 Radioembolization Superior or Comparable to Transarterial Chemoembolization for Treating Hepatocellular Carcinoma?
Pan, Ling-Hui
Zhao, Chang
Ma, Yi-Long
GASTROENTEROLOGY, 2017, 152 (06) : 1627 - +
[24] Long-term outcome analysis of Y90 radioembolization in hepatocellular carcinoma
Lee, Hannah M.
Alder, Laura
Nguyen, Matthew
Dougherty, Sean C.
Qu, Yuesheng
Thacker, Leroy R.
Poklepovic, Andrew
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (03) : 1378 - 1391
[25] Does Y90 Radioembolization Prolong Overall Survival Compared With Chemoembolization in Patients With Hepatocellular Carcinoma?
Garin, Etienne
Pallard, Xavier
Edeline, Julien
GASTROENTEROLOGY, 2017, 152 (06) : 1624 - +
[26] Transarterial Y90 radioembolization versus chemoembolization for patients with hepatocellular carcinoma: A meta-analysis
Zhang, Yafei
Li, Yiming
Ji, Hong
Zhao, Xin
Lu, Hongwei
BIOSCIENCE TRENDS, 2015, 9 (05) : 289 - 298
[27] Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Salem, Riad
Gordon, Andrew C.
Mouli, Samdeep
Hickey, Ryan
Kallini, Joseph
Gabr, Ahmed
Mulcahy, Mary F.
Baker, Talia
Abecassis, Michael
Miller, Frank H.
Yaghmai, Vahid
Sato, Kent
Desai, Kush
Thornburg, Bartley
Benson, Al B.
Rademaker, Alfred
Ganger, Daniel
Kulik, Laura
Lewandowski, Robert J.
GASTROENTEROLOGY, 2016, 151 (06) : 1155 - +
[28] PROGNOSTIC FACTORS AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED BY Y90-RADIOEMBOLIZATION (Y90-RE)
Inarrairaegui, M.
D'Avola, D.
Rodriguez, M.
Bilbao, J. I.
Martinez-Cuesta, A.
Alegre, F.
Herrero, I.
Quiroga, J.
Prieto, J.
Sangro, B.
JOURNAL OF HEPATOLOGY, 2009, 50 : S291 - S291
[29] A study of pembrolizumab (pembro) in combination with Y90 radioembolization in patients (pts) with poor prognosis hepatocellular carcinoma (HCC) with preserved liver function
Mcree, Autumn Jackson
Helft, Paul R.
Harris, William Proctor
Sanoff, Hanna Kelly
Johnson, Matthew
Yu, Menggang
O'Neil, Bert
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[30] Long-term outcome analysis of Y90 radioembolization in hepatocellular carcinoma.
Alder, Laura
Nguyen, Matthew
Qu, James
Lee, Hannah
Thacker, Leroy R.
Dougherty, Sean
Poklepovic, Andrew Stewart
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

← 1 2 3 4 5 →